Table 2.
Outcomes | References | DEX (n) | Control (n) | Estimated benefit [95% CI] | P value | I2 (%) |
---|---|---|---|---|---|---|
Pain intensity at rest | ||||||
1 h postoperatively | 7,21–25,28–31 | 256 | 238 | WMD = −1.57 [−1.94, −1.20] | 0.00001 | 89 |
2 h postoperatively | 7,22–25,28–31 | 235 | 215 | WMD = −1.46 [−1.82, −1.10] | 0.00001 | 89 |
4 h postoperatively | 7,24,25,29–31 | 145 | 145 | WMD = −1.37 [−1.76, −0.97] | 0.00001 | 84 |
6 h postoperatively | 7,21,23–25,28,30,31 | 186 | 188 | WMD = −1.26 [−1.61, −0.92] | 0.00001 | 83 |
8 h postoperatively | 7,22,29–31 | 140 | 120 | WMD = −1.02 [−1.41, −0.64] | 0.00001 | 70 |
12 h postoperatively | 7,21,24,25,29–31 | 166 | 168 | WMD = −0.55 [−0.88, −0.23] | 0.0009 | 69 |
24 h postoperatively | 7,21–23,25,29,31 | 181 | 163 | WMD = −0.34 [−0.68, 0.00] | 0.05 | 59 |
Pain intensity on movement | ||||||
1 h postoperatively | 22,29,30 | 90 | 70 | WMD = −1.71 [−2.39, −1.03] | 0.00001 | 86 |
2 h postoperatively | 22,29,30 | 90 | 70 | WMD = −1.80 [−2.25, −1.36] | 0.00001 | 70 |
8 h postoperatively | 22,29,30 | 90 | 70 | WMD = −1.29 [−1.57, −1.02] | 0.00001 | 32 |
Other outcomes | ||||||
Morphine-equivalents 0–24 h (mg) | 21,23,28–31 | 151 | 153 | WMD = −8.54 [−11.96, −5.13] | 0.00001 | 95 |
Time to first analgesic request (min) | 7,21–31 | 316 | 278 | WMD = 257.57 [209.86, 305.28] | 0.00001 | 93 |
PONV | 7,21–31 | 316 | 278 | RR = 1.37 [0.52, 3.62] | 0.52 | 0 |
Hypotension | 7,21–31 | 316 | 278 | RR = 2.20 [0.67, 7.23] | 0.19 | 0 |
Bradycardia | 7,21–31 | 316 | 278 | RR = 2.20 [0.81, 5.97] | 0.12 | 0 |
Somnolence | 22,23,28,31 | 120 | 100 | RR = 1.54 [0.07, 36.11] | 0.79 | 0 |
DEX group vs. control group for all comparisons.
Pain intensity was scored with a visual analog scale as: 0 = no pain, 10 = the most severe pain imaginable.
Morphine-equivalents were calculated as: morphine 10 mg = tramadol 100 mg = fentanyl 0.1 mg, intravenously.
DEX, dexmedetomidine; PONV, postoperative nausea and vomiting; WMD, weighted mean difference; RR, risk ratio; CI, confidence interval.